Position history for CITADEL ADVISORS LLC's holdings in BIOXCEL THERAPEUTICS
CITADEL ADVISORS LLC previously held 0 shares of BTAI (BIOXCEL THERAPEUTICS), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Other major holders of BTAI: ADAGE CAPITAL PARTNERS GP, L.L.C., ALLIANCEBERNSTEIN L.P., VICTORY CAPITAL MANAGEMENT INC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $2.62 |
0 |
| 2025-Q2 | New | 11,378 | - | $20,594 | 0.0% | $1.77 | 29 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $20.48 | 0 |